Revvity (RVTY) Cash from Investing Activities (2009 - 2026)
Revvity's (RVTY) quarterly Cash from Investing Activities came in at -$78.3 million in Q2 2026, down 1127.22% YoY from $7.6 million in Q2 2025, and down 318.65% on a QoQ basis from $35.8 million in Q4 2025.
Revvity (RVTY) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Revvity (RVTY) has 18 years of Cash from Investing Activities data on file, last reported at -$78.3 million in Q2 2026.
- Quarterly Cash from Investing Activities fell 1127.22% year-over-year to -$78.3 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$89.2 million (down 111.33% YoY) and the FY2025 annual result came in at -$17.4 million, down 102.24% from the prior year.
- Cash from Investing Activities retreated to -$78.3 million in Q2 2026, from $35.8 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $3.9 billion in Q1 2023 to a low of -$556.7 million in Q3 2023.
- A 5-year average of $252.2 million and a median of -$18.2 million in 2024 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities surged 131.39% — and 2026, when it plunged 1127.22%.
- Tracing RVTY's Cash from Investing Activities over 5 years: stood at -$48.6 million in 2022, then slumped by 753.53% to -$414.8 million in 2023, then surged by 131.39% to $130.2 million in 2024, then slumped by 72.5% to $35.8 million in 2025, then tumbled by 318.65% to -$78.3 million in 2026.
- The last three Cash from Investing Activities figures came in at -$78.3 million (Q2 2026), $35.8 million (Q4 2025), and -$37.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 164.00 Mn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -10.15 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -25.50 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -77.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -381.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -32.14 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -122.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -1.94 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -134.00 Mn |
| 10 | Revvity | 12.89 Bn | 12.03 Bn | 387.66 Mn | -78.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -78.27 Mn |
| Apr 5, 2026 | -78.27 Mn |
| Dec 28, 2025 | 35.80 Mn |
| Dec 28, 2025 | 35.80 Mn |
| Sep 28, 2025 | -37.28 Mn |
| Sep 28, 2025 | -37.28 Mn |
| Jun 29, 2025 | -9.49 Mn |
| Jun 29, 2025 | -9.49 Mn |
| Mar 30, 2025 | -6.38 Mn |
| Mar 30, 2025 | -6.38 Mn |
| Dec 29, 2024 | 130.19 Mn |
| Dec 29, 2024 | 130.19 Mn |
| Sep 29, 2024 | 690.18 Mn |
| Sep 29, 2024 | 690.18 Mn |
| Jun 30, 2024 | -26.03 Mn |
| Jun 30, 2024 | -26.03 Mn |
| Mar 31, 2024 | -18.18 Mn |
| Mar 31, 2024 | -18.18 Mn |
| Dec 31, 2023 | -414.81 Mn |
| Dec 31, 2023 | -414.81 Mn |